Insider trade

Director received an award of 1,930.01 CVS derivative securities

Traded May 14, 2026 · Filed May 15, 2026

CVS HealthCVS

1,930.01
Derivative units · @ $97.15

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: May 14, 2026
Reporting period: Not applicable
Filed with the SEC: May 15, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000064803-26-000058
Filed / recorded

May 15, 2026, 9:04 PM UTC

Added to OQRO

Oct 2, 2026, 3:52 AM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

CVS HEALTH Corp

Issuer CIK

64803

Ticker

CVS

Reporting person

Larry Robbins

Relationship

Director

Security

Deferred Stock Units

Table

Derivative (Table II)

Transaction date

May 14, 2026

Transaction code

A

Shares / units

1,930.0051

Price per share

$97.15

Acquired / disposed

Acquired (A)

Shares owned after

10,147.6418

Ownership form

Direct

Amendment

No

Footnotes from the filing

Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the 2017 Incentive Compensation Plan.
Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.